Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Karen H. Antman, Lois Ayash, Anthony Elias et al. · Journal of Clinical Oncology · 1992 · 374 citations

Medicine, Oncology, Pharmacotherapy +17

Preclinical evaluation of docetaxel (Taxotere).

François Lavelle, Bissery Mc, Cécile Combeau et al. · PubMed · 1995 · 216 citations

Law, Pharmacology, Pharmacotherapy +2

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.

Simon A. Jones, Eric P. Winer, C Vogel et al. · Journal of Clinical Oncology · 1995 · 194 citations

Medicine, Oncology, Pharmacology +13

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

Barbara Weber, Charles Vogel, Stephen E. Jones et al. · Journal of Clinical Oncology · 1995 · 193 citations

Medicine, Oncology, Pharmacology +14